# Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers

> **NCT00941018** · PHASE1 · COMPLETED · sponsor: **Resolvyx Pharmaceuticals, Inc** · enrollment: 56 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RX-10001

## Key facts

- **NCT ID:** NCT00941018
- **Lead sponsor:** Resolvyx Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2009-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941018, "Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00941018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*